Retatrutide is a groundbreaking triple-action GLP-1, GIP, and Glucagon receptor agonist, available for research purposes only. This advanced peptide provides cutting-edge benefits for weight loss, metabolism, and overall metabolic health. Available in 10mg, 20mg, and 30mg, Retatrutide is the most potent option for researchers focusing on comprehensive metabolic and weight loss studies.

Key Benefits:

• For research purposes only
• Triple-action mechanism (GLP-1, GIP, and Glucagon) for superior metabolic effects
• Available in 10mg, 20mg, and 30mg for customized research dosing
• Ideal for advanced weight loss and metabolic health research

Why Retatrutide is the “King Kong” of GLP Medications:

Retatrutide stands out due to its triple-action mechanism targeting GLP-1, GIP, and Glucagon receptors. This makes it the most powerful option available for research purposes only when compared to other GLP medications, offering unparalleled results in weight loss and metabolic health research. 24% weight loss in less time than Mounjaro.

Can last between 6-10 weeks as you need less product.